Medx Health

Medx Health OCF Margin

The Operating Cash Flow Margin of Medx Health (MDX.V) as of Oct 18, 2026 is -788.11 %. In the previous year, Operating Cash Flow Margin was -512.70 % — a change of 53.72% (lower).

OCF Margin

-788.11 %

YoY

53.72%

Last updated:

Operating Cash Flow Margin of Medx Health is 2025 -788.11 % . Operating Cash Flow Margin of Medx Health was 2024 -512.70 % . It decreases by 53.72% lower compared to the previous year.

The Medx Health OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2018
-239.70 CAD
Jan 1, 2019
-154.00 CAD
Jan 1, 2020
-548.78 CAD
Jan 1, 2021
-802.11 CAD
Jan 1, 2022
-548.53 CAD
Jan 1, 2023
-750.32 CAD
Jan 1, 2024
-512.70 CAD
Jan 1, 2025
-788.11 CAD
The Medx Health OCF Margin history
YEAROCF MarginYoY
-788.11 %+53.72%
-512.70 %-31.67%
-750.32 %+36.79%
-548.53 %-31.61%
-802.11 %+46.16%
-548.78 %+256.34%
-154.00 %-35.75%
-239.70 %+78.14%
-134.55 %-17.43%
-162.95 %+255.78%
-45.80 %-53.47%
-98.44 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medx Health Stock analysis

What does Medx Health do? Medx Health Corp, trading under the ticker MDX.V, is a Canadian company headquartered in Mississauga, Ontario. The company went public on February 12, 2008, and operates within the Health Care sector, specifically in the Health Care industry. Medx Health Corp develops, manufactures, and sells medical devices and software. Its primary focus is on skin health, utilizing SIAscopy technology for skin-related screening tools. The company offers a telemedicine platform called SIAscopy on DermSecure, which integrates its SIAscopy scanning technology for web-based operations. Products include SIAMETRICS, SIMSYS, and MoleMate, which are hand-held devices that use light-based technology to examine moles and lesions up to two millimeters beneath the skin surface in a pain-free, non-invasive manner. These devices are designed for the rehabilitation market, providing phototherapy treatments using low-level laser and light-emitting diode technology to address pain and tissue damage. The company's offerings are centered around non-invasive skin screening and phototherapeutic applications, targeting both diagnostic and therapeutic needs within the health care sector. Medx Health Corp's products are intended for medical professionals and patients seeking advanced, non-invasive solutions for skin health management and rehabilitation. Medx Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medx Health stock

Operating Cash Flow Margin of Medx Health is -788.11 % in 2025.

Operating Cash Flow Margin of Medx Health changed from -512.70 % to -788.11 %, representing a 53.72% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Medx Health since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Medx Health with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Medx Health

All Key Metrics — Medx Health